Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer. Shioi I, Ogawa H, Naito R, Endo M, et al. Anticancer Res 2024;44:3013-3023.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shioi I, Ogawa H, Naito R, Endo M, et al. Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer. Anticancer Res 2024;44:3013-3023.
PMID: 38925838